bupropion has been researched along with Carcinoma, Hepatocellular in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lee, CM | 1 |
Liu, KH | 1 |
Singer, G | 1 |
Miller, GW | 1 |
Li, S | 1 |
Jones, DP | 1 |
Morgan, ET | 1 |
1 other study available for bupropion and Carcinoma, Hepatocellular
Article | Year |
---|---|
High-Throughput Production of Diverse Xenobiotic Metabolites with Cytochrome P450-Transduced Huh7 Hepatoma Cell Lines.
Topics: Bupropion; Carcinoma, Hepatocellular; Cell Line; Cytochrome P-450 Enzyme System; Humans; Liver Neopl | 2022 |